Johnson & Johnson is relaunching sales of a promising heart-rhythm device after a safety scare, but with a new warning for doctors that analysts say could hamper its market potential ...

Medtronic (MDT) beat estimates for profits in the last quarter thanks to strong demand for diabetes and heart devices. Earnings per share ...